U. Matulonis

724 citations
33 papers · 596 indexed · h-index 9

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 10%
    • Vascular Tumors and Angiosarcomas
    • PARP inhibition in cancer therapy
    • CAR-T cell therapy research

Papers in

    • Ovarian cancer diagnosis and treatment 14
    • HER2/EGFR in Cancer Research 6
    • Cancer Treatment and Pharmacology 5
    • PARP inhibition in cancer therapy 4

U. Matulonis

31 papers receiving 581 citations

Peers

U. Matulonis
Comparison fields: 5 of 56
  • Reproductive Medicine 122
  • Oncology 342
  • Pulmonary and Respiratory Medicine 252
  • Immunology 126
  • Obstetrics and Gynecology 45
Replace R Algeri with:
R Algeri Italy
Nicole Kelbick United States
J. Cheng United States
M.R. Sertoli Italy
Ewa Chmielowska Poland
Anna Maria Mosconi Italy
Kenji Yorita Japan
Volker Moebus Germany
Awatif Al‐Nafussi United Kingdom
Malti Kshirsagar United States
U. Matulonis relative to R Algeri Italy R Algeri's profile →
Citations per field
00.5×11×
R Algeri · 1×
Citations per year

Countries citing papers authored by U. Matulonis

Since Specialization
Citations

This map shows the geographic impact of U. Matulonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Matulonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Matulonis more than expected).

Fields of papers citing papers by U. Matulonis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Matulonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Matulonis. The network helps show where U. Matulonis may publish in the future.

Co-authors

The 25 scholars most cited alongside U. Matulonis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with U. Matulonis Line = papers co-authored together U. Matulonis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2004250
2 1995108
3 201148
4 200643
5 201129
6 200719
7 201916
8 201812
9 201811
10 20058
11 20225
12 20195
13 20104
14 20194
15 20094
16 20114
17 19994
18 20124
19 20222
20 20182

About U. Matulonis

U. Matulonis is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Biophysics, having authored 33 papers that have together received 596 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (14 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (5 papers), PARP inhibition in cancer therapy (4 papers), Cancer therapeutics and mechanisms (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), BRCA gene mutations in cancer (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Reproductive Medicine (122 citations), Oncology (342 citations), Pulmonary and Respiratory Medicine (252 citations), Immunology (126 citations) and Obstetrics and Gynecology (45 citations). U. Matulonis has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Chrysoula Dosiou, P Mauch, GJ Freeman, Christine Lamont, LM Nadler, JD Griffin, Michael V. Seiden, María Teresa Rugeles López, Jennifer Canniff and Priscilla Merriam. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology, Clinical Infectious Diseases and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026